Blur Relief
- Manufacturer
- TRP Company
- Effective date
- 2022-08-15
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 12
- Source
- legacy-cache
- Hydrated at
- 2026-08-01 21:55:31
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
OTC - ACTIVE INGREDIENT SECTION
| Active Ingredients | Purpose |
| Cineraria Maritima HPUS 5X | Cloudy Vision |
| Calcarea fluorica HPUS 13X | Opacities |
| Conium Maculatum HPUS 6x | Poor Night Vision |
| Euphrasia (Eyebright) HPUS 6x | Dryness, Redness |
| Gelsemium HPUS 6x | Blurry vision |
| Natrum Muriaticum HPUS 6x | Difficulty reading |
| Ruta Graveolens HPUS 6x | Tired Eyes |
The letters HPUS indicate that the components of this product are officially monographed in the Homeopathic Pharmacopoeia of the United States.
INDICATIONS & USAGE SECTION
Uses:*
According to homeopathic indications these ingredients provide temporary relief from symptoms such as:
• Blurry Vision
• Dry, Red & Tired Eyes
• Poor Night Vision (Glare)
• Difficulty reading after serious causes have been ruled out by a physician.
*These statements are based upon traditional homeopathic practice. They have not been reviewed by the Food and Drug Administration.
WARNINGS SECTION
Warnings:
A PHYSICIAN SHOULD ALWAYS BE CONSULTED TO RULE OUT SERIOUS CAUSES.
For External Use Only.
- This product is intended to complement not replace, standard medical treatment.
- Initial worsening of symptoms may occur.
- Physician should always be consulted to rule out serious conditions.
OTC - PREGNANCY OR BREAST FEEDING SECTION
- If pregnant or breast-feeding, ask a health professional before use.
WARNINGS SECTION
- Contact lens wearers consult physician prior to using.
- To avoid contamination - do not touch tip to any surface.
- Replace cap after every use.
- Use within 30 days of opening.
- EXPIRATION DATE ONLY REFERS TO THE UNOPENED BOTTLE.
- The use of this container by more than one person may spread infection.
Do not use:
• If solution changes color or becomes cloudy. • If you frequently contract infections that do not clear up easily. • If you experience eye pain or changes in vision.
Stop use and ask a doctor if:
• You experience eye pain, changes in vision, continued redness or irritation of the eye. • The condition worsens. • The condition persists for more than 72 hours.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
• Keep out of reach of children.
SPL UNCLASSIFIED SECTION
• In case of accidental ingestion, get medical help or contact a Poison Control Center right away.
DOSAGE & ADMINISTRATION SECTION
Directions:
• Suitable for adults and children ages 2 and over. • Children under the age of 2: Consult a physician before use. • Squeeze 1-3 drops in the eye. • Use several times per day as needed. • Use within 30 days of opening. • Expiration date only refers to unopened bottle. • Homeopathic remedies may not be effective for everyone. • May take up to 60 days to see results.
SPL UNCLASSIFIED SECTION
Other information:
- There are no known contraindications
-
Active ingredients are micro-diluted in accordance with the Homeopathic Pharmacopoeia of the
United States and are therefore non-toxic with no known side effects.
Blur Relief Homeopathic Sterile Eye Drops are homeopathic dilutions:
see
www.thereliefproducts.com for details.
- Store at room temperature 15° to 30° C (59° to 86° F).
- Keep bottle tightly closed
INACTIVE INGREDIENT SECTION
Inactive ingredients:
Benzalkonium Chloride, Purified Water, Sodium Chloride, Sodium Phosphate Dibasic, Sodium Phosphate Monobasic
Questions or comments?
www.thereliefproducts.com, 1-888-969-6855
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 17312-002-11 | 2025-11-17 | C162847 | 48780-1 | 1e7a6dab-17a2-a2ce-e063-dadaa90aadf7 | Blur Relief |
| 17312-002-11 | 2024-07-30 | C162847 | 48780-1 | 1e7a6dab-17a2-a2ce-e063-dadaa90aadf7 | Blur Relief |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 17312-002 | BLUR RELIEF (JACOBAEA MARITIMA, CALCIUM FLUORIDE, CONIUM MACULATUM FLOWERING TOP, EUPHRASIA STRICTA, GELSEMIUM SEMPERVIRENS ROOT, SODIUM CHLORIDE, RUTA GRAVEOLENS FLOWERING TOP) LIQUID [TRP COMPANY] | 12 | Legacy NDC | 20220816_6c029a53-a4d1-4af6-8ce5-915a2bea67b2.zip |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Calcium Fluoride | ACTIVE INGREDIENT | O3B55K4YKI | 2 | |
| Conium Maculatum Flowering Top | ACTIVE INGREDIENT | Q28R5GF371 | 2 | |
| Euphrasia Stricta | ACTIVE INGREDIENT | C9642I91WL | 2 | |
| Gelsemium Sempervirens Root | ACTIVE INGREDIENT | 639KR60Q1Q | 2 | |
| Jacobaea Maritima | ACTIVE INGREDIENT | U4B223LS4X | 2 | |
| Ruta Graveolens Flowering Top | ACTIVE INGREDIENT | N94C2U587S | 2 | |
| Sodium Chloride | ACTIVE INGREDIENT | 451W47IQ8X | 2 | |
| Conium Maculatum Flowering Top | ACTIVE MOIETY | Q28R5GF371 | 2 | |
| Euphrasia Stricta | ACTIVE MOIETY | C9642I91WL | 2 | |
| Fluoride Ion | ACTIVE MOIETY | Q80VPU408O | 2 | |
| Gelsemium Sempervirens Root | ACTIVE MOIETY | 639KR60Q1Q | 2 | |
| Jacobaea Maritima | ACTIVE MOIETY | U4B223LS4X | 2 | |
| Ruta Graveolens Flowering Top | ACTIVE MOIETY | N94C2U587S | 2 | |
| Sodium Cation | ACTIVE MOIETY | LYR4M0NH37 | 2 | |
| Benzalkonium Chloride | INACTIVE INGREDIENT | F5UM2KM3W7 | 2 | |
| Citric Acid Monohydrate | INACTIVE INGREDIENT | 2968PHW8QP | 2 | |
| Sodium Phosphate, Dibasic | INACTIVE INGREDIENT | GR686LBA74 | 2 | |
| Sodium Phosphate, Monobasic | INACTIVE INGREDIENT | 3980JIH2SW | 2 | |
| Water | INACTIVE INGREDIENT | 059QF0KO0R | 2 |
Products#
Every source-derived product name is available through these pages.
- Blur Relief
- Jacobaea Maritima, Calcium Fluoride, Conium Maculatum Flowering Top, Euphrasia Stricta, Gelsemium Sempervirens Root, Sodium Chloride, Ruta Graveolens Flowering Top
- BENZALKONIUM CHLORIDE
- WATER
- SODIUM PHOSPHATE, DIBASIC
- CITRIC ACID MONOHYDRATE
- SODIUM PHOSPHATE, MONOBASIC
- JACOBAEA MARITIMA
- CALCIUM FLUORIDE
- FLUORIDE ION
- CONIUM MACULATUM FLOWERING TOP
- EUPHRASIA STRICTA
- GELSEMIUM SEMPERVIRENS ROOT
- SODIUM CHLORIDE
- SODIUM CATION
- RUTA GRAVEOLENS FLOWERING TOP
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 17312-002 | 17312-002-11 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Benzalkonium Chloride | BENZALKONIUM CHLORIDE | F5UM2KM3W7 | SOLUTION / NASAL | 40.46 mg/100ml | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / INTRATHECAL | ADJ PH | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION, SOLUTION / INTRAMUSCULAR | 26 mg | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | DOUCHE / VAGINAL | 0.07 %w/w | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / RESPIRATORY (INHALATION) | 8 mg | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | OINTMENT / TOPICAL | 1 mg | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION, SOLUTION, CONCENTRATE / IRRIGATION | 1 mg | ||
| Benzalkonium Chloride | BENZALKONIUM CHLORIDE | F5UM2KM3W7 | CLOTH / TOPICAL | NA | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / PERIDURAL | NA | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SHAMPOO, SUSPENSION / TOPICAL | 0.25 %w/v | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | TABLET, FILM COATED / ORAL | 42 mg | ||
| Sodium Phosphate, Dibasic | SODIUM PHOSPHATE, DIBASIC | GR686LBA74 | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / SUBCUTANEOUS | 2.98 mg | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION, CONCENTRATE / INTRAVENOUS | NA | ||
| Benzalkonium Chloride | BENZALKONIUM CHLORIDE | F5UM2KM3W7 | SHAMPOO / TOPICAL | 0.2 %w/w | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / BUCCAL | NA | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION, SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | 38 mg | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | AEROSOL, FOAM / RECTAL | 7 mg | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | CONCENTRATE / ORAL | 5.3 mg/1ml | ||
| Benzalkonium Chloride | BENZALKONIUM CHLORIDE | F5UM2KM3W7 | INJECTION / INTRALESIONAL | 1 mg | ||
| Sodium Phosphate, Dibasic | SODIUM PHOSPHATE, DIBASIC | GR686LBA74 | CONCENTRATE / ORAL | 17 mg/5ml | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | GEL / TOPICAL | 1 mg | ||
| Benzalkonium Chloride | BENZALKONIUM CHLORIDE | F5UM2KM3W7 | LOTION / TOPICAL | 0.1 %w/w | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / NASAL | 2.8 mg/1ml | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / TOPICAL | 17 mg | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INHALANT / RESPIRATORY (INHALATION) | NA | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | TABLET, CHEWABLE / ORAL | 7 mg | ||
| Benzalkonium Chloride | BENZALKONIUM CHLORIDE | F5UM2KM3W7 | SOLUTION / RESPIRATORY (INHALATION) | 0.02 %w/w | ||
| Benzalkonium Chloride | BENZALKONIUM CHLORIDE | F5UM2KM3W7 | GEL / OPHTHALMIC | 0.01 %w/w | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | CREAM / TOPICAL | 4 mg | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / ORAL | 446 mg | ||
| Benzalkonium Chloride | BENZALKONIUM CHLORIDE | F5UM2KM3W7 | SOLUTION / AURICULAR (OTIC) | 0.01 %w/v | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | POWDER, FOR SOLUTION / TOPICAL | NA | ||
| Sodium Phosphate, Dibasic | SODIUM PHOSPHATE, DIBASIC | GR686LBA74 | INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS | 40 mg | ||
| Benzalkonium Chloride | BENZALKONIUM CHLORIDE | F5UM2KM3W7 | LIQUID / NASAL | 0.2 mg/1ml | ||
| Benzalkonium Chloride | BENZALKONIUM CHLORIDE | F5UM2KM3W7 | SOLUTION/ DROPS / TOPICAL | 0.01 %w/v | ||
| Benzalkonium Chloride | BENZALKONIUM CHLORIDE | F5UM2KM3W7 | OINTMENT / TOPICAL | 0.03 %w/w | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION, SOLUTION / SUBCUTANEOUS | 26 mg | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION, SOLUTION / INTRA-ARTICULAR | ADJ PH | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SWAB / TOPICAL | 0.05 %w/w | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | TABLET, ORALLY DISINTEGRATING / ORAL | 83 mg | ||
| Sodium Phosphate, Dibasic | SODIUM PHOSPHATE, DIBASIC | GR686LBA74 | CREAM / TOPICAL | 0.1 %w/w | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / INTRAPLEURAL | ADJ PH | ||
| Benzalkonium Chloride | BENZALKONIUM CHLORIDE | F5UM2KM3W7 | SOLUTION/ DROPS / AURICULAR (OTIC) | 0 %w/v | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / INTRA-ARTICULAR | ADJ PH | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | TROCHE / ORAL | 12 mg | ||
| Sodium Phosphate, Dibasic | SODIUM PHOSPHATE, DIBASIC | GR686LBA74 | INJECTION / INTRADERMAL | 0.2 %w/v | ||
| Sodium Phosphate, Dibasic | SODIUM PHOSPHATE, DIBASIC | GR686LBA74 | TABLET, EXTENDED RELEASE / ORAL | 143 mg | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | POWDER, FOR SUSPENSION / ORAL | 840 mg | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS | 608 mg | ||
| Benzalkonium Chloride | BENZALKONIUM CHLORIDE | F5UM2KM3W7 | SPRAY, METERED / NASAL | 1 mg | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / SOFT TISSUE | ADJ PH | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION/ DROPS / TOPICAL | 0.01 %w/v | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION, SOLUTION / INTRAVENOUS | 396 mg | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / INTRAOCULAR | 1 mg | ||
| Sodium Phosphate, Monobasic | SODIUM PHOSPHATE, MONOBASIC | 3980JIH2SW | SYSTEM / TOPICAL | 14.2 mg | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / INTRAVENOUS | 10 mg | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | DROPS / ORAL | NA | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | CREAM / VAGINAL | 0.49 %w/w | ||
| Sodium Phosphate, Dibasic | SODIUM PHOSPHATE, DIBASIC | GR686LBA74 | INJECTION / INTRAVENOUS | 200 mg | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION, POWDER, FOR SOLUTION / INTRAMUSCULAR | NA |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 43d19741-98aa-09bd-e063-6294a90ae4fa | 6c029a53-a4d1-4af6-8ce5-915a2bea67b2 | 2025-11-17 | Warnings | 6c029a53-a4d1-4af6-8ce5-915a2bea67b2 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.



